Advertisement

GI & Endoscopy

Researchers at Fox Chase Cancer Center have found that an investigational form of naproxen, called nitric oxide-donating naproxen (NO-naproxen), can block one of the earliest molecular changes that lead to colorectal cancer development while also reducing gastrointestinal toxicity, a relatively…

Advertisement

Mentor, Ohio-based US Endoscopy is planning a $4.7 million expansion, so the company can continue to design, make and sell its gastrointestinal endoscopy products, with the goal of moving into other specialties, according to a report in MedCity News.

Bernard McDonnell, DO, a retired physician and current surveyor for Healthcare Facilities Accreditation Program, says that while a vast majority of the GI facilities he surveys do a good job of adhering to standards that protect patient safety, the routine…

Advertisement